Results 111 to 120 of about 76,328,651 (141)
Exploring C4-Modified Sialosides in Siglec Affinity and Selectivity
The family of Sialic-acid-binding ImmunoGlobulin-like LECtins, known as Siglecs, play a vital role in the hematopoietic, immune and nervous systems of many mammals, including humans.
Madge, Paul
core +1 more source
Human intravenous immunoglobulins (IVIg) contain natural autoantibodies against the inhibitory lectin-receptors Siglec-8 and Siglec-9. These two members of the Siglec family are known to mediate both inhibitory and death signals.
Simon, Hans-Uwe +5 more
core +1 more source
Breast cancer (BRCA) is among the most prevalent cancers and is responsible for numerous patient fatalities. Immunotherapy has emerged as a promising approach to cancer treatment.
Huan Lai +5 more
doaj +1 more source
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. [PDF]
Moreira RS +8 more
europepmc +1 more source
Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion [PDF]
Neisserial adhesin A (NadA) is a meningococcal surface protein included as recombinant antigen in 4CMenB, a protein-based vaccine able to induce protective immune responses against Neisseria meningitidis serogroup B (MenB).
Perrotta, A +37 more
core +1 more source
Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies
BACKGROUND: Human intravenous immunoglobulin (IVIg) preparations are used for the treatment of autoimmune and allergic diseases. Natural autoantibodies are believed to contribute to IVIg-mediated anti-inflammatory effects.
Schaub, Alexander +22 more
core +1 more source
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia. [PDF]
Pillsbury CE +18 more
europepmc +1 more source
Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma. [PDF]
Mutka M +4 more
europepmc +1 more source
Immune checkpoint blockade targeting the programmed cell death protein-1 (PD-1) and its ligand PD-L1 has revolutionized cancer immunotherapy; however, a substantial proportion of patients exhibit primary or acquired resistance, underscoring the existence
WANG Shihui, ZHENG Tianqing
doaj
Siglec-15 Expression in Gastric Carcinoma and Its Association With Clinicopathological Variables. [PDF]
Al Badr S +5 more
europepmc +1 more source

